Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Amoy Diagnostics Co Ltd (300685) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7906
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kits. AmoyDx also provides super-ARMS EGFR mutation detection kit, HER-2 gene amplification analysis kit, HPV detection kit, human papillomavirus genotyping detection kit, and high-risk human papillomavirus detection kit. The company’s products are used for the treatment and diagnostics of lung cancer, colon cancer, and leukemia. It serves domestic and international oncology sector. The company markets its products through a network of distributors in Argentina, Iceland, Norway, Sweden, Austria, Ireland, the Philippines, Switzerland, and Belgium, among other countries. AmoyDx is headquartered in Xiamen, China.

Amoy Diagnostics Co Ltd (300685) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Amoy Diagnostics Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
CANbridge Life Sciences and Amoy Diagnostics Enter into Agreement 10
Merck Enters into Co-Development Agreement with Amoy Diagnostics 11
MoBiTec Enters into Distribution Agreement with Amoy Diagnostics 12
Amoy Diagnostics Enters Into Agreement With OxOnc Development For Gene Fusions Detection Kits 13
Equity Offering 14
Amoy Diagnostics Raises USD41.2 Million in IPO 14
Amoy Diagnostics Co Ltd – Key Competitors 15
Amoy Diagnostics Co Ltd – Key Employees 16
Amoy Diagnostics Co Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Amoy Diagnostics Co Ltd, Medical Equipment, Key Facts, 2017 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Deals By Market, 2012 to YTD 2018 8
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CANbridge Life Sciences and Amoy Diagnostics Enter into Agreement 10
Merck Enters into Co-Development Agreement with Amoy Diagnostics 11
MoBiTec Enters into Distribution Agreement with Amoy Diagnostics 12
Amoy Diagnostics Enters Into Agreement With OxOnc Development For Gene Fusions Detection Kits 13
Amoy Diagnostics Raises USD41.2 Million in IPO 14
Amoy Diagnostics Co Ltd, Key Competitors 15
Amoy Diagnostics Co Ltd, Key Employees 16

List of Figures
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • ZincX Resources Corp:企業の戦略・SWOT・財務分析
    ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kitoku Shinryo Co., Ltd.:企業の戦略・SWOT・財務情報
    Kitoku Shinryo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kitoku Shinryo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Korean Reinsurance Company:企業の戦略・SWOT・財務情報
    Korean Reinsurance Company - Strategy, SWOT and Corporate Finance Report Summary Korean Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Scynexis Inc (SCYX):企業の財務・戦略的SWOT分析
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company offers pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C …
  • Sobha Ltd:企業の戦略・SWOT・財務情報
    Sobha Ltd - Strategy, SWOT and Corporate Finance Report Summary Sobha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Jazz Pharmaceuticals Plc (JAZZ)-製薬・医療分野:企業M&A・提携分析
    Summary Jazz Pharmaceuticals plc (Jazz Pharmaceuticals) is a specialty biopharmaceutical company which identifies, develops and commercializes medicines with focus on narcolepsy, cancer, pain and psychiatry. Its major marketed products include Xyrem, sodium oxybate oral solution, for the treatment o …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Lotus Bakeries NV:企業の戦略・SWOT・財務情報
    Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report Summary Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Banyan Tree Holdings Ltd:戦略・SWOT・企業財務分析
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Promimic AB:医療機器:M&Aディール及び事業提携情報
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets nano-thin surface modifications for all implant materials and geometries. The company offers thin HA surface modification for orthopedic and dental implants, which improves osseointegration and bone healing around inte …
  • Westar Energy Inc (WR)-エネルギー分野:企業M&A・提携分析
    Summary Westar Energy, Inc. (Westar Energy) is a vertically integrated energy utility that generates, transmits and distributes electricity. The company owns and operates a generation portfolio of coal-fired, nuclear, natural gas-based, renewable and diesel-based power plants. It also procures elect …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆